Lawrence Pemble
Chief Operating Officer at CannBioRex Pharmaceuticals Corp.
Profile
Lawrence Pemble is currently the Chief Operating Officer & Director at CannBioRex Pharmaceuticals Corp., as well as the Chief Operating Officer & Director at Katexco Pharmaceuticals Corp.
and the Chief Operating Officer at African Cannabis Corp.
In the past, he served as the President, CEO, Secretary & Treasurer at Grey Fox Holdings Corp., Director at Global Gaming Technologies Corp., Chief Operating Officer & Executive Director at HemoGenyx Pharmaceuticals Plc, Director at Auscan Resources, Inc., and Chief Operating Officer at 180 Life Sciences Corp.
Lawrence Pemble active positions
| Companies | Position | Start |
|---|---|---|
CannBioRex Pharmaceuticals Corp.
 CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Chief Operating Officer | 2018-04-30 |
Katexco Pharmaceuticals Corp.
 Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Chief Operating Officer | - |
African Cannabis Corp.
 African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Chief Operating Officer | - |
Former positions of Lawrence Pemble
| Companies | Position | End |
|---|---|---|
| AUSCAN RESOURCES INC. | Chief Executive Officer | 2019-06-04 |
| GLOBAL GAMING TECHNOLOGIES CORP. | Director/Board Member | 2019-08-14 |
| HEMOGENYX PHARMACEUTICALS PLC | Chief Operating Officer | 2018-11-04 |
| GRAY FOX PETROLEUM CORP | Chief Executive Officer | 2015-04-01 |
| 180 LIFE SCIENCES CORP. | Chief Operating Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
| HEMOGENYX PHARMACEUTICALS PLC | Health Technology |
| AUSCAN RESOURCES INC. | Process Industries |
| 180 LIFE SCIENCES CORP. | Health Technology |
| Private companies | 4 |
|---|---|
Grey Fox Holdings Corp.
 Grey Fox Holdings Corp. RestaurantsConsumer Services Grey Fox Holdings Corp. was engaged in the acquisition of revenue generating subsidiaries to increase company revenues and shareholder value. The company was founded by Viatcheslav Gelshteyn on September 22, 2011 and was headquartered in Longwood, FL. | Consumer Services |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Lawrence Pemble